Minerva Surgical, Inc. (UTRS) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Healthcare Information Services secteur d'activité. Le siège social de l'entreprise est situé à Santa Clara, CA, United States. Le PDG actuel est Darin Hammers.
UTRS a date d'introduction en bourse 2021-10-22, 174 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $888.00.
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
